...
首页> 外文期刊>Psychiatry and Clinical Psychopharmacology >A Case of Chronic Schizophrenia Who were Switched from Combined Treatment to Monotherapy and Achieved a Decrease in Positive Symptoms after Lowering the Clozapine Dose
【24h】

A Case of Chronic Schizophrenia Who were Switched from Combined Treatment to Monotherapy and Achieved a Decrease in Positive Symptoms after Lowering the Clozapine Dose

机译:降低氯氮平剂量的慢性精神分裂症患者从联合治疗转为单一疗法并减少了阳性症状

获取原文
           

摘要

Despite the limited evidence to support the combination of antipsychotics in treatment resistant schizophrenia in the literature, this situation is common in clinical practice. Treatment guidelines recommend monotherapy for schizophrenia primarily. In this article, a chronic schizophrenic case whose treatment is changed from combination of clozapine with aripiprazole to clozapine monotherapy and whose positive symptoms decreased with the decrease of clozapine doses 900 mg/day to 625 mg/day is reported.
机译:尽管在文献中仅有有限的证据支持抗精神病药联合治疗耐药性精神分裂症,但这种情况在临床实践中很常见。治疗指南建议主要用于精神分裂症的单一疗法。本文报道了一种慢性精神分裂症病例,其治疗从氯氮平与阿立哌唑的组合改为氯氮平单药治疗,其积极症状随着氯氮平剂量从900 mg /天减少至625 mg /天而降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号